The quiet end of the relabeller trading as Vantris Bio
A proper account of an operation that existed, and of what closing it cost.
April 2025 — Vol. 2, No. 4
Page 2 of 4 of this archive, newest first.
Also filed — page 2
the rolling newsroom, April 2025Argentina pharmacy body issues counselling standards for tirzepatide initiation
The evidence base is thin and the document says so, which is to its credit.
What changed at QSC in April, and what the company will not say about it
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
Janoshik result on a Guangzhou retatrutide lot lands 2.2 points below the supplier’s figure
The result is unremarkable. What the report omits is not.
The 19-day notice: how a compounding wind-down works in Turkey
The document is four pages. Three of them are about dates.
Chengdu export categories for peptide intermediates were quietly renamed
Follow the resin, not the catalogue.
Denmark declines to reimburse liraglutide outside a specialist service
Efficacy was never the question in this appraisal. Duration of treatment was.
The relabeller trading as Vantris Bio closes after 16 years
A proper account of an operation that existed, and of what closing it cost.
STEP 2 extension data: what happens after the trial stops
A design note rather than a result: what the comparator was, and what that permits you to conclude.
The Netherlands caps tirzepatide prescribing to 4 specialist centres
Efficacy was never the question in this appraisal. Duration of treatment was.
Inspectors cite Calder Vale Peptides of Skipton over sterility assurance
The observation that closes a facility is rarely the dramatic one.
The quiet end of the relabeller trading as Vantris Bio
A proper account of an operation that existed, and of what closing it cost.
Switzerland declines to reimburse liraglutide outside a specialist service
Efficacy was never the question in this appraisal. Duration of treatment was.
Wuxi export categories for peptide intermediates were quietly renamed
Follow the resin, not the catalogue.
Why summer is a documented quality problem in this trade
The route did not close because of a rule about peptides.
The online reseller trading as Adamant Research Supply closes after 6 years
A proper account of an operation that existed, and of what closing it cost.
Italy caps semaglutide prescribing to 18 specialist centres
Efficacy was never the question in this appraisal. Duration of treatment was.
What changed at KP in April, and what the company will not say about it
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
France pharmacy body issues counselling standards for exenatide initiation
The evidence base is thin and the document says so, which is to its credit.
Holograms, QR codes and other things that are not verification
Reported from the analysis, not from a warning notice.
The consolidator trading as Meridian Freight Partners enters a consent decree and stops sterile preparation
The observation that closes a facility is rarely the dramatic one.
The United Kingdom pharmacy body issues counselling standards for dulaglutide initiation
The evidence base is thin and the document says so, which is to its credit.
What the new Spain guidance says about stopping
The evidence base is thin and the document says so, which is to its credit.
From the floor in Hong Kong: 13 posters, one theme
Reported from the sessions, and from the two hours afterwards.
What the new Singapore guidance says about stopping
The evidence base is thin and the document says so, which is to its credit.
What a 39% rise in coupling-reagent prices does to a 5 mg vial
Follow the resin, not the catalogue.
The online reseller trading as Adamant Research Supply enters a consent decree and stops sterile preparation
The observation that closes a facility is rarely the dramatic one.
A supplier suspends shipping to Italy after 8 consecutive customs detentions
The route did not close because of a rule about peptides.
Wuxi export categories for peptide intermediates were quietly renamed
Follow the resin, not the catalogue.
Independent analysis puts a KP liraglutide lot at 95.5%, against 91.6% on the certificate
The result is unremarkable. What the report omits is not.